
The CLEARTEST NT-pro BNP is a rapid diagnostic test for the qualitative detection of the cardiac biomarker NT-pro BNP (N-terminal pro-B-type natriuretic peptide), which is used primarily in cases of suspected heart failure and for monitoring the progress of therapy. NT-pro BNP is produced in the left ventricle of the heart and released in increased amounts when the heart muscle is stretched by pressure or volume loading .
This test enables the treating physician to perform a rapid and differentiated assessment in cases of unclear shortness of breath – particularly for distinguishing between cardiac and pulmonary causes. It is therefore a valuable tool in the diagnosis and follow-up of chronic or acute heart failure.
Areas of application
-
Diagnosis and monitoring of heart failure
-
Differential diagnosis of respiratory distress: heart failure vs. lung disease
-
Follow-up of drug therapy for heart failure
-
Application in practice, clinic and emergency areas
Advantages at a glance
-
Qualitative detection of NT-pro BNP – cardiac heart failure marker
-
Results in just 10 minutes
-
Lower detection limit: 0.45 ng/ml
-
Enables rapid differential diagnosis of dyspnea
-
Easy to use – ideal for point-of-care use
-
Suitable for patients with risk factors such as hypertension, coronary heart disease, age over 65
Delivery information:
PZN:
WEEE number:
Assistive device number:
Manufacturer:
Tel:
Email:
VAT ID number: